The Company is developing Teverelix® as a best-in-class market product for advanced prostate cancer patients with high CV risk and a first in class product for Acute Urinary Retention Relapse preventi ...

The COVID-19 pandemic highlighted an urgent need for efficient, durable, and widely accessible vaccines. This prompted several important innovations in vaccine technology, and researchers continue to ...

DARKIRIS' AIGC brand AIDEPTUS has released its latest showcase in the field of AI generative content. The sample reel covers the creation of diverse character archetypes, ranging from realistic to ...

Join us to learn how to model and optimize phased-array antennas using an RF Module. See how simulation can guide design decisions and improve performance for 5G, 6G, radar, and satellite systems ...

With this simple, all-in-one solution you can create a stunning site with no technical know-how, but could Wix be a bit too simple for you?

Relay Therapeutics gets US FDA Breakthrough Therapy Designation for zovegalisib to treat advanced breast cancer: Cambridge, Massachusetts Thursday, February 5, 2026, 16:00 Hrs [IS ...